SNN Share Price

Open 28.50 Change Price %
High 28.78 1 Day -0.11 -0.38
Low 28.45 1 Week 0.69 2.46
Close 28.76 1 Month 0.12 0.42
Volume 413536 1 Year -4.50 -13.53
52 Week High 36.11
52 Week Low 26.97
SNN Important Levels
Resistance 2 29.07
Resistance 1 28.94
Pivot 28.66
Support 1 28.58
Support 2 28.45
NYSE USA Most Active Stocks
BAC 22.57 1.85%
BAC 22.57 1.85%
BAC 22.57 1.85%
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
CHK 7.58 0.00%
More..
NYSE USA Top Gainers Stocks
IPI 2.49 36.81%
IPI 2.49 36.81%
IPI 2.49 36.81%
POM 26.93 26.79%
POM 26.93 26.79%
VRS 6.20 15.24%
VRS 6.20 15.24%
CVI 21.14 14.33%
SAB 7.20 12.50%
SAB 7.20 12.50%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
OIBR 0.17 -43.33%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

Smith & Nephew SNATS, Inc. (NYSE: SNN)

SNN Technical Analysis 3
As on 7th Dec 2016 SNN Share Price closed @ 28.76 and we RECOMMEND Sell for LONG-TERM with Stoploss of 32.54 & Sell for SHORT-TERM with Stoploss of 29.85 we also expect STOCK to react on Following IMPORTANT LEVELS.
SNN Target for December
1st Target up-side 29.61
2nd Target up-side 30.41
3rd Target up-side 31.21
1st Target down-side 27.33
2nd Target down-side 26.53
3rd Target down-side 25.73
SNN Other Details
Segment EQ
Market Capital 9844970496.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.smith-nephew.com
SNN Address
SNN
15 Adam Street
London, WC2N 6LA
United Kingdom
Phone: 44 20 7401 7646
Fax: 44 20 7930 3353
SNN Latest News
Interactive Technical Analysis Chart Smith & Nephew SNATS, Inc. ( SNN NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Smith & Nephew SNATS, Inc.
SNN Business Profile
Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the advanced surgical devices and advanced wound management sectors worldwide. The company’s Advanced Surgical Devices segment offers orthopaedic reconstruction implants for hip, knee, and shoulder joints; and ancillary products, such as bone cement and mixing systems used in cemented reconstruction joint surgery. It also provides sports medicine products, which offer surgeons an array of instruments, technologies, and implants to perform minimally invasive surgery of the joints, including knee, hip, and shoulder repair; and trauma and extremities products consisting of internal and external devices and other products, including shoulder fixation and orthobiological materials used in the stabilization of fractures and deformity correction procedures. In addition, this segment provides arthroscopy enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, as well as offers radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissues to healthcare providers. The company’s Advanced Wound Management segment offers a range of initial wound bed preparation and full wound closure products. Its products are targeted at chronic wounds associated with the older population, such as pressure sores and venous leg ulcers; and products for the treatment of wounds, such as burns and invasive surgery. Smith & Nephew plc primarily serves medical and surgical treatments and service providers. The company was founded in 1856 and is headquartered in London, the United Kingdom.